Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 12.93% is 144% above its 5-year average of -29.26%, near the high end of its 5-year range (-65.21%–12.93%).
As of the fiscal period ended Tuesday, June 30, 2026. 177.18% above its 12-month average of -16.75%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 12.93%.
RETURN ON INVESTED CAPITAL (ROIC)
12.93%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-16.75%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-40.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-29.26%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-42.03%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+177.18%
CURRENT VS 3Y AVG
+131.88%
CURRENT VS 5Y AVG
+144.18%
CURRENT VS 10Y AVG
+130.76%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+136.27%
vs the sector median at left
Zevra Therapeutics, Inc.
Market Cap
$625.58M
Return on Invested Capital (ROIC)
12.93%
TTM Avg
-16.75%
3Y Avg
-40.56%
5Y Avg
-29.26%
Market Cap
$619.58M
Return on Invested Capital (ROIC)
-49.73%
TTM Avg
-57.30%
3Y Avg
-49.74%
5Y Avg
-42.74%
Market Cap
$633.55M
Return on Invested Capital (ROIC)
-42.02%
TTM Avg
-66.01%
3Y Avg
-48.82%
5Y Avg
-55.42%
Market Cap
$618.31M
Return on Invested Capital (ROIC)
-17.48%
TTM Avg
-24.56%
3Y Avg
-18.89%
5Y Avg
-16.21%
Market Cap
$612.16M
Return on Invested Capital (ROIC)
-26.94%
TTM Avg
-40.40%
3Y Avg
-38.31%
5Y Avg
-45.27%
Market Cap
$647.46M
Return on Invested Capital (ROIC)
-90.42%
TTM Avg
-73.13%
3Y Avg
-82.56%
5Y Avg
-61.25%
Market Cap
$600.01M
Return on Invested Capital (ROIC)
58.60%
TTM Avg
17.42%
3Y Avg
-47.16%
5Y Avg
-23.48%
Market Cap
$657.89M
Return on Invested Capital (ROIC)
-31.32%
TTM Avg
-38.51%
3Y Avg
-38.51%
5Y Avg
-38.51%
Market Cap
$653.74M
Return on Invested Capital (ROIC)
1.97%
TTM Avg
18.16%
3Y Avg
11.04%
5Y Avg
1.26%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zevra Therapeutics, Inc. (ZVRA) | $625.58M | 12.93% | -16.75% | -40.56% | -29.26% |
| SOPHiA GENETICS S.A. (SOPH)vs › | $619.58M | -49.73% | -57.30% | -49.74% | -42.74% |
| Aura Biosciences, Inc. (AURA)vs › | $633.55M | -42.02% | -66.01% | -48.82% | -55.42% |
| OmniAb, Inc. (OABI)vs › | $618.31M | -17.48% | -24.56% | -18.89% | -16.21% |
| Climb Bio, Inc. (CLYM)vs › | $612.16M | -26.94% | -40.40% | -38.31% | -45.27% |
| Prime Medicine, Inc. (PRME)vs › | $647.46M | -90.42% | -73.13% | -82.56% | -61.25% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $600.01M | 58.60% | 17.42% | -47.16% | -23.48% |
| Starling Oncology, Inc. (STLN)vs › | $657.89M | -31.32% | -38.51% | -38.51% | -38.51% |
| MiMedx Group, Inc. (MDXG)vs › | $653.74M | 1.97% | 18.16% | 11.04% | 1.26% |
| AngioDynamics, Inc. (ANGO)vs › | $593.31M | -20.75% | -20.15% | -33.64% | -24.57% |
ROIC
12.9%
ROE
26.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 12.93% |
| 2026-03-31 | -19.60% |
| 2025-12-31 | -24.62% |
| 2025-09-30 | -23.66% |
| 2025-06-30 | -28.81% |
| 2025-03-31 | -49.32% |
| 2024-12-31 | -60.39% |
| 2024-09-30 | -54.92% |
| 2024-06-30 | -65.21% |
| 2024-03-31 | -46.78% |
| 2023-12-31 | -36.03% |
| 2023-09-30 | -37.27% |
| 2023-06-30 | -40.06% |
| 2023-03-31 | -58.78% |
| 2022-12-31 | -39.37% |
| 2022-09-30 | -32.48% |
| 2022-06-30 | -27.06% |
| 2022-03-31 | -0.89% |
| 2021-12-31 | 6.00% |
| 2021-09-30 | 5.51% |
| 2021-06-30 | 6.28% |
| 2021-03-31 | 5.90% |
| 2020-12-31 | -138.05% |
| 2020-09-30 | -107.57% |
| 2020-06-30 | -33.45% |
| 2020-03-31 | -659.58% |
| 2019-12-31 | -400.65% |
| 2019-09-30 | -273.89% |
| 2019-06-30 | -1023.77% |
| 2019-03-31 | -474.50% |
| 2018-12-31 | -309.28% |
| 2018-09-30 | -1462.10% |
| 2018-06-30 | -235.37% |
| 2018-03-31 | -126.68% |
| 2017-12-31 | -75.35% |
| 2017-09-30 | -68.48% |
| 2017-06-30 | -59.01% |
| 2017-03-31 | -53.52% |
| 2016-12-31 | -47.92% |
| 2016-09-30 | -38.19% |
| 2016-06-30 | -30.26% |
| 2016-03-31 | -24.77% |
| 2015-12-31 | -44.92% |
| 2015-09-30 | -40.14% |
| 2015-06-30 | -33.88% |
| 2015-03-31 | -184.54% |
| 2014-12-31 | -155.34% |
| 2014-09-30 | -56.51% |
